N-n-butyl haloperidol iodide mitigates myocardial ischemia/reperfusion injury through activation of SIRT1-Nrf2 signaling loop
Journal of Cardiovascular Pharmacology
APRIL 1, 2024
Abstract: N-n-butyl haloperidol iodide (F2), a derivative of haloperidol developed by our group, exhibits potent antioxidative properties and confers protection against cardiac ischemia/reperfusion (I/R) injury. Copyright © 2024 The Author(s). The protective mechanisms by which F2 ameliorates I/R injury remain obscure.
Let's personalize your content